Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Cantor Fitzgerald
McKesson
Medtronic
Citi
Deloitte
Covington
McKinsey

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020323

« Back to Dashboard

NDA 020323 describes VIVELLE, which is a drug marketed by Novartis and is included in two NDAs. Additional details are available on the VIVELLE profile page.

The generic ingredient in VIVELLE is estradiol. There are seventy-five drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 020323
Tradename:VIVELLE
Applicant:Novartis
Ingredient:estradiol
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020323

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.0375MG/24HR
Approval Date:Oct 28, 1994TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.05MG/24HR
Approval Date:Oct 28, 1994TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.075MG/24HR
Approval Date:Oct 28, 1994TE:RLD:No

Expired US Patents for NDA 020323

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis VIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 020323-005 Aug 16, 2000 ➤ Sign Up ➤ Sign Up
Novartis VIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 020323-003 Oct 28, 1994 ➤ Sign Up ➤ Sign Up
Novartis VIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 020323-001 Oct 28, 1994 ➤ Sign Up ➤ Sign Up
Novartis VIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 020323-001 Oct 28, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Citi
Daiichi Sankyo
Queensland Health
Chinese Patent Office
Julphar
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.